Awards & Recognition

Parexel has been shortlisted for the 2026 Scrip Awards in the Best Contract Research Organization — Full-Service Provider category, recognizing the critical role that CROs play in drug development. The Scrip Awards, organized by Citeline, bring together industry leaders to honor and celebrate the best innovations and achievements in the global biopharma landscape from the past year.

Parexel has been nominated for the inaugural 2026 Prix Galien USA Patient First Award, a prestigious recognition celebrating excellence in clinical research and patient-centered care. Parexel’s nomination recognizes the work of Parexel and the Foundation Fighting Blindness. The inaugural Prix Galien USA Patient First Award recognizes organizations that embed patient voices into research and care delivery, advance equitable access and translate patient insights into meaningful improvements in health outcomes and quality of life.

Parexel was recognized as a World’s Top Disability Inclusive Business based on its high performance on the Disability Index®, the leading global benchmark for disability inclusion in business. This recognition reflects a company-wide commitment to creating an environment where colleagues and patients – regardless of physical ability or other differences – can participate and thrive in clinical research.

Parexel was recognized by TIME magazine as one of America's Best Private Companies of 2026. This recognition reflects Parexel’s ongoing commitment to fostering an inclusive, supportive workplace while advancing innovations that improve patients’ lives around the world. To identify companies for this top 500 list, TIME partnered with data firm Statista. Their research-based ranking focused on two key factors: employee satisfaction and societal impact.

Parexel received a 2026 Triangle Business Journal (TBJ) Life Sciences Award in the Most Innovative Clinical Research Organization (CRO) category. These awards recognize individuals and organizations advancing innovation across the life sciences, including biotechnology, pharmaceuticals, clinical research, medical devices, diagnostics and human health. Parexel was recognized for our industry-leading clinical development impact, combining regulatory leadership, therapeutic expertise, AI driven innovation and meaningful Triangle community leadership that advances biomedical R&D.

Parexel was named the winner of the 2026 NEXT Award for Patient Leadership from Medidata Solutions. This award recognizes Parexel’s commitment to patient-focused technology and patient insights to improve the clinical trial experience and decrease burden on trial participants. Award winners were recognized at Medidata NEXT in NYC on March 11.

Parexel was named one of Newsweek's "America's Greatest Workplaces for Culture, Belonging & Community 2026," recognizing companies that have made an inclusive workplace environment the foundation of their organizational success. This comprehensive ranking evaluates U.S. employers with more than 1,000 employees based on their performance across metrics that matter most to women, minorities and diverse demographic groups.

Parexel was recognized with the Triangle Business Journal's 2026 Space Award for Top Interior Space/Build-Out Project for our new global headquarters in Raleigh's North Hills Innovation District (NHID). The Triangle Business Journal's Space Awards honor the Triangle market's top commercial real estate deals and developments.

Parexel was recognized in the Human Rights Campaign Foundation’s 2026 Corporate Equality Index for our commitment to LGBTQ+ equality and inclusion. The recognition – with a five-point score increase from the previous year – reflects the dedication of our Global Inclusion team’s leadership, advocacy of our Parexel Pride business resource group, and commitment of our global colleagues who champion inclusion every day. The Human Rights Campaign Foundation’s State of the Workplace for LGBTQ+ Americans and Corporate Equality Index 2026 provides a research-based snapshot of LGBTQ+ experiences in U.S. workplaces and a national benchmark of corporate policies, practices, and benefits pertinent to LGBTQ+ employees.

Parexel was recognized for its participation and transparency on environmental issues and sustainability by CDP, a global environmental non-profit that runs the world’s only independent disclosure system. Parexel has disclosed to CDP for the past 12 years. CDP is fully aligned with the Task Force on Climate Related Financial Disclosures (TCFD) framework and maintains the world’s largest repository of environmental data. Its scoring system is widely used by investors and procurement teams seeking to accelerate progress towards a net-zero, sustainable and earth-positive global economy.